Insulet | PODD - Nettoeinkommen





Nettoeinkommen Veränderung Datum
Abbott USD 928M 149M 2026-06
Align Technology USD 108.29M 4.48M 2026-06
AtriCure USD 8.96M 8.85M 2026-06
Baxter International USD 126M 141M 2026-06
Becton, Dickinson and Co. USD 377M 688M 2026-06
Boston Scientific USD 907M 434M 2026-06
Cardinal Health USD 399M 68M 2026-03
Cooper Companies USD -77.9M 208.7M 2026-03
Dexcom USD 249.1M 49.6M 2026-06
Edwards Lifesciences USD 241.9M 138.8M 2026-06
Eli Lilly USD 7.1B 301M 2026-06
Globus Medical USD 151.57M 27.27M 2026-06
ICU Medical USD 19.09M 11.04M 2026-06
Inogen USD -5.96M 373K 2024-09
Insulet USD 95M 3.9M 2026-06
Integra LifeSciences USD 4.48M 9.1M 2026-06
J&J USD 5.53B 299M 2026-06
Medtronic USD 1.24B 100M 2026-03
Merit Medical Systems USD 41M 2.99M 2026-03
Roche Holding CHF 6.87B 1.4B 2026-06
Solventum Corp USD 92M 79M 2026-06
Stryker USD 1.28B 531M 2026-06
Tandem Diabetes Care USD -21.17M 775K 2026-06
Teleflex USD 99.69M 107.85M 2026-06
West Pharmaceutical Services USD 154M 15.2M 2026-06
Zimmer Biomet Holdings USD 198.3M 39.8M 2026-06